Under what conditions can rituximab treatment be considered for patients with stiff person syndrome?

Rituximab may be considered for stiff person syndrome patients refractory to conventional treatments like IVIG, though evidence is limited, and efficacy appears variable. Further research is necessary to establish clear guidelines and identify patient subgroups most likely to benefit.